Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance.
- befree-2016 importedOn "2016-02-19" NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance.
- NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_assertion wasGeneratedBy ECO_0000203 NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance.
- NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_assertion wasDerivedFrom befree-2016 NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance.
- NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_assertion SIO_000772 24756793 NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance.
- NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_assertion evidence source_evidence_literature NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance.
- NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_assertion description "[The high efficacy of crizotinib in ALK- and ROS-positive lung cancer as new molecular targets beside the epidermal growth factor receptor (EGFR) underscores the importance of molecular typing in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175943.RACgjWvBFR10kfeenFJD7_nxjgx3gc5D6TxTy5BmpCtXY130_provenance.